|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-5-1
|
|
pubmed:abstractText |
Oxaliplatin could increase the efficacy of fluorouracil (5-FU)/folinic acid chemoradiotherapy in rectal cancer. We tested three dose levels to identify a feasible oxaliplatin dose for combination therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2433-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11331322-Adult,
pubmed-meshheading:11331322-Aged,
pubmed-meshheading:11331322-Aged, 80 and over,
pubmed-meshheading:11331322-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11331322-Combined Modality Therapy,
pubmed-meshheading:11331322-Female,
pubmed-meshheading:11331322-Fluorouracil,
pubmed-meshheading:11331322-Humans,
pubmed-meshheading:11331322-Leucovorin,
pubmed-meshheading:11331322-Male,
pubmed-meshheading:11331322-Middle Aged,
pubmed-meshheading:11331322-Organoplatinum Compounds,
pubmed-meshheading:11331322-Rectal Neoplasms
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Medical Oncology Unit, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
